Finance

Beta
Lists
600529:SHA
Shandong Pharmaceutical Glass Co Ltd
CNÂ¥19.70
+2.60%
(+0.50) 1D
Jun 5, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600529...
Open
CNÂ¥19.31
High
CNÂ¥20.30
Low
CNÂ¥19.04
Mkt. cap
12.74B
Avg. vol.
9.91M
Volume
25.85M
Dividend
2.34%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 20, 2026
P/E ratio
19.59
52-wk high
CNÂ¥23.99
52-wk low
CNÂ¥17.30
EPS
CNÂ¥1.01
Shares outstanding
424.98M
No. of employees
7K
Open
CNÂ¥19.31
High
CNÂ¥20.30
Low
CNÂ¥19.04
Mkt. cap
12.74B
Avg. vol.
9.91M
Volume
25.85M
Dividend
2.34%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
May 20, 2026
P/E ratio
19.59
52-wk high
CNÂ¥23.99
52-wk low
CNÂ¥17.30
EPS
CNÂ¥1.01
Shares outstanding
424.98M
No. of employees
7K
News stories
From sources across the web
About Shandong Pharmaceutical Glass Co Ltd
CEO-
Employees6.78K
Founded1970
Headquarters-
SectorMedical device
Websitepharmglass.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.13B
1.03B
1.07B
1.22B
Cost of goods sold
805.16M
603.35M
812.53M
822.10M
Cost of revenue
805.16M
603.35M
812.53M
822.10M
Research and development expenses
45.99M
42.82M
36.30M
36.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.51M
99.38M
66.76M
80.66M
Operating expense
169.83M
137.74M
121.26M
138.76M
Total operating expenses
974.99M
741.09M
933.79M
960.86M
Operating income
156.40M
285.58M
139.71M
258.21M
Other non operating income
-4.88M
3.13M
-5.22M
-8.26M
EBT including unusual items
174.63M
206.84M
182.44M
239.23M
EBT excluding unusual items
167.94M
289.83M
146.33M
257.77M
Income tax expense
27.12M
35.53M
35.26M
38.02M
Effective tax rate
15.53%
17.18%
19.33%
15.89%
Other operating expenses
15.16M
-169.23K
22.86M
10.75M
Net income
147.51M
171.31M
147.17M
201.21M
Net profit margin
13.04%
16.69%
13.71%
16.50%
Earnings per share
0.21
0.25
0.21
0.29
Interest and investment income
7.60M
9.95M
8.05M
8.53M
Interest expense
-6.21K
-7.06K
-495.98K
-706.06K
Net interest expenses
7.60M
9.94M
7.56M
7.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
254.77M
381.78M
237.03M
355.52M
Gain or loss from assets sale
-417.48K
417.48K
-1.45M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer